Dose Optimisation Study of ART621 in Subjects Diagnosed With Rheumatoid Arthritis Taking Methotrexate
Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical trial is to establish what dose level and dosing frequency is
optimal in the treatment of rheumatoid arthritis patients with ART621.